F M Trademark

Trademark Overview

On Thursday, May 27, 2021, a trademark application was filed for F M with the United States Patent and Trademark Office. The USPTO has given the F M trademark a serial number of 90981081. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, August 21, 2024. This trademark is owned by Frontier Medicines Corporation. The F M trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Small molecule pharmaceuticals for the treatment of cancer

Pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer
f m

General Information

Serial Number90981081
Word MarkF M
Filing DateThursday, May 27, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of stylized letters "F" and "M".
Goods and ServicesSmall molecule pharmaceuticals for the treatment of cancer
Pseudo MarkFRONTIER MEDICINES
Goods and ServicesPharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 23, 2021
Primary Code005
First Use Anywhere DateMonday, November 20, 2023
First Use In Commerce DateMonday, November 20, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 23, 2021
Primary Code042
First Use Anywhere DateSunday, July 18, 2021
First Use In Commerce DateSunday, July 18, 2021

Trademark Owner History

Party NameFrontier Medicines Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFrontier Medicines Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, August 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 31, 2021NEW APPLICATION ENTERED
Wednesday, February 9, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022SOU EXTENSION 1 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU EXTENSION 2 GRANTED
Thursday, April 27, 2023SOU EXTENSION 2 FILED
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022SOU EXTENSION 1 FILED
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 3, 2023SOU EXTENSION 3 GRANTED
Friday, November 3, 2023SOU EXTENSION 3 FILED
Friday, November 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 28, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 17, 2024USE AMENDMENT FILED
Friday, May 17, 2024DIVISIONAL REQUEST RECEIVED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024TEAS STATEMENT OF USE RECEIVED
Monday, June 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, July 27, 2024DIVISIONAL PROCESSING COMPLETE
Saturday, July 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 18, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 21, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 22, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, August 21, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

research development pharmaceutical cancer treatment pharmaceuticals molecule products services small